Mark Watson

Medicine & Life Sciences

1. Breast Neoplasms 100%
2. Genes 85%
3. Neoplasms 82%
4. Gene Expression 57%
5. Mutation 56%
6. Acute Myeloid Leukemia 55%
7. Transcriptome 51%
8. Gene Expression Profiling 46%
9. Astrocytoma 41%
10. Laser Capture Microdissection 41%
11. Genome 39%
12. Estrogen Receptors 34%
13. Messenger RNA 30%
14. Oligonucleotide Array Sequence Analysis 28%
15. Neurofibrosarcoma 28%
16. Uteroglobin 27%
17. Recurrence 25%
18. Triple Negative Breast Neoplasms 25%
19. Drug Therapy 24%
20. Adenocarcinoma of Lung 23%
21. Non-Small Cell Lung Carcinoma 22%
22. Breast 22%
23. Bone Marrow 21%
24. Colorectal Neoplasms 21%
25. Whole Genome Sequencing 21%
26. RNA 20%
27. Biomarkers 20%
28. Prostate 19%
29. Bone Marrow Cells 19%
30. Proteins 19%
31. Neurofibromatosis 1 18%
32. Neoplasm Metastasis 18%
33. DNA 17%
34. Proteogenomics 17%
35. Meningioma 17%
36. Survival 17%
37. Therapeutics 17%
38. Aromatase Inhibitors 16%
39. High-Throughput Nucleotide Sequencing 15%
40. Proteomics 15%
41. Microbiota 15%
42. Uterine Cervical Neoplasms 14%
43. Acute Promyelocytic Leukemia 14%
44. Adenocarcinoma 14%
45. Datasets 13%
46. Lung Neoplasms 13%
47. Aromatase 12%
48. Squamous Cell Carcinoma 12%
49. Cell Line 12%
50. Irinotecan 12%